Your browser has 'Cookies' disabled, alert boxes will continue to appear without this feature.
Activity description

99243 - Statins: Optimising therapy, addressing intolerance Small group meeting

National Prescribing Service Ltd

This small group meeting with a trained facilitator provides practices with a clinical update and an opportunity for interactive discussion with peers about the management of patients using lipid-modifying medicines. This includes discussion about the use of cardiovascular risk assessment, optimising statin therapy and the management of statin-associated muscle symptoms. Data from the NPS MedicineInsight program will be provided to help GPs and practice staff draw insights from current practice.

Relevance to General Practice

We have come a long way with lipid management in Australian general practice. The latest news and evidence can further enhance and reinforce patient care including:
* Who should be using lipid-modifying medicines
* How to optimise statin therapy
* What is true statin intolerance, particularly statin-associated muscle symptoms (SAMS) and how it can be assessed and managed

Guidelines continue to reinforce a cardiovascular risk approach to prescribing lipid-modifying medicines. Despite this, there is evidence that decisions to start therapy are being based on individual risk factors, or inaccurate risk estimates – leading to under or over prescribing of statin therapy.

An adequate trial of statin therapy before adding a second agent, including titrating to maximal tolerated dose and checking for adherence to medicines and lifestyle changes is recommended to optimise LDL-C lowering.

A systematic approach is recommended in guidelines to assess and manage true SAMS.

Learning outcomes

  1. Describe the role of absolute cardiovascular risk assessment before prescribing lipid-modifying therapy
  2. Use an adequate trial of statins to optimise lipid lowering before adding a second agent
  3. Identify the symptoms and risk factors of statin-associated muscle symptoms (SAMS) and apply a systematic approach to assessing and managing SAMS
  4. Discuss systems in your practice and prioritise areas for improvement in the management of patients using lipid-modifying medicines

Domains of General Practice

D1. Communication skills and the patient-doctor relationship
  • Ways in which health can be optimised and maintained are communicated to patients, family members and carers

D2. Applied professional knowledge and skills
  • Rational prescribing and medication monitoring is undertaken

D3. Population health and the context of general practice
  • The patterns and prevalence of disease are incorporated into screening and management practices

D4. Professional and ethical role
  • Professional knowledge and skills are reviewed and developed

D5. Organisational and legal dimensions
  • Quality and safety is enhanced through the effective use of information systems

Curriculum Contextual Units

  • Rural health
  • Adult health
  • Care of older people

Session summary


Monday 1 May 2017 12:00am - Friday 31 May 2019 12:00am

This activity is readily available at any time


Various GPs' practice


Face to face




All attendees welcome

Target Audience

GPs and practice team

For more information contact...

Customer Service
T: 02 8217 8700